News
- Elanco Announces Agreement to Acquire Kindred BiosciencesJune 16, 2021 6:30 AM EDT
- Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by ParvovirusJune 2, 2021 8:31 AM EDT
- Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XIMay 25, 2021 8:42 AM EDT
Events
- Tuesday, June 8, 2021 from 1:30 PM to 1:55 PM EDT
- Wednesday, June 2, 2021 from 11:00 AM to 11:25 AM EDT
- Tuesday, May 11, 2021 4:30 PM EDT
|
KindredBio proudly supports
Rabies Free Africa
Press Release
Dr.Richard Chin , Chief Executive Officer, will be available for one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones.
Conference Details:
Date:March 10, 2021
Presentation time: 2:25 –2.50p.m. ET , Virtual Track 3
Webcast URL: Click here
Date:March 9-10, 2021
Presentation time: On demand access beginningMarch 9
Webcast URL: Click here
An archived version of the above webcasts will be available for 30 days on the KindredBio website.
About Kindred Biosciences
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
SOURCEKindred Biosciences, Inc.